CLOVER HEALTH INVESTMENTS CORP. - CLASS A COMMON
3.5250
13-March-25 10:07:00
15 minutes delayed
Stocks
-0.0850
-2.35%
Today's range
3.4700 - 3.7050
ISIN
N/A
Source
NASDAQ
-
Clover Health to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
30 Jan 2023 16:05:00 By Nasdaq GlobeNewswire
-
Clover Health Provides Business Update and Issues Partial Guidance for Full-Year 2023
10 Jan 2023 09:15:00 By Nasdaq GlobeNewswire
-
Clover Health to Present at 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023
04 Jan 2023 16:05:00 By Nasdaq GlobeNewswire
-
Clover Health Issues December 2022 Investor Frequently Asked Questions
13 Dec 2022 16:30:00 By Nasdaq GlobeNewswire
-
Dr. Anna Loengard Joins Clover Health Board of Directors
30 Nov 2022 16:05:00 By Nasdaq GlobeNewswire
-
Clover Health Reports Third Quarter 2022 Financial Results
07 Nov 2022 16:05:02 By Nasdaq GlobeNewswire
-
Clover Health to Present at Credit Suisse 31st Annual Healthcare Conference on November 10, 2022
03 Nov 2022 16:05:01 By Nasdaq GlobeNewswire
-
Clover Health to Report Third Quarter 2022 Financial Results on November 7, 2022
10 Oct 2022 16:05:00 By Nasdaq GlobeNewswire
-
Clover Health Debuts New Medicare Advantage Plans for 2023
06 Oct 2022 16:05:00 By Nasdaq GlobeNewswire
-
Clover Health to Present at 2022 Wells Fargo Healthcare Conference on September 7, 2022
31 Aug 2022 16:05:00 By Nasdaq GlobeNewswire
-
Clover Health Reports Second Quarter 2022 Financial Results
08 Aug 2022 16:08:41 By Nasdaq GlobeNewswire
-
Clover Health Announces Evolution of Leadership Roles to Best Support Future Growth
08 Aug 2022 16:06:00 By Nasdaq GlobeNewswire
-
Clover Health to Present at Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022
03 Aug 2022 16:05:02 By Nasdaq GlobeNewswire
-
Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
26 Jul 2022 16:43:49 By Nasdaq GlobeNewswire
-
Dr. Carladenise Armbrister Edwards Joins Clover Health Board of Directors
26 Jul 2022 16:05:01 By Nasdaq GlobeNewswire
-
Clover Health Announces Planned Medicare Advantage Expansion for 2023
14 Jul 2022 16:05:00 By Nasdaq GlobeNewswire
-
Clover Health to Report Second Quarter 2022 Financial Results on August 8, 2022
11 Jul 2022 16:05:00 By Nasdaq GlobeNewswire
-
Clover Health Set to Join Russell 3000® Index
24 Jun 2022 16:05:00 By Nasdaq GlobeNewswire
-
Clover Health Appoints Scott J. Leffler as Chief Financial Officer
25 May 2022 16:05:00 By Nasdaq GlobeNewswire
-
Clover Health Reports First Quarter 2022 Financial Results
09 May 2022 16:05:01 By Nasdaq GlobeNewswire